Answers are grounded in this paper and cite their sources.
Objectives: The study is planned to investigate the antidiabetic activity of hesperidin on Streptozotocin (STZ)-induced diabetes mellitus in Swiss Albino mice. Materials and Methods: The Swiss Albino mice were divided into six groups viz., normal control, diabetic control, insulin 0.75 IU/kg, hesperidin 100, 200 and 400 mg/kg, respectively (n = 6/group). All groups received treatments once daily for 21 consecutive days, except normal and diabetic control groups. The random blood glucose and body weight were determined on the pre-study day, 7, 14 and 21st day of the experiment. At the end of the study, blood samples were collected through the retro-orbital plexus puncture and used for the biochemical analysis. Results: Throughout the study, the diabetic control mice showed a significant increase in glucose level when compared with that of the control group, whereas the animals treated with insulin or hesperidin showed a significant reduction in the levels of glucose when compared with that of the diabetic control group. In biochemical analysis, the mice administered with the STZ showed a significant increase in the levels of AST, ALP and creatinine when compared with that of the control group. The mice administered with insulin or hesperidin showed a significant decrease in the AST and ALP when compared with that of the diabetic control group. Conclusion: Hesperidin showed significant antidiabetic activity on STZ-induced diabetes mellitus in mice.
No takes yet. Share an insight, caveat, or question.
Parasuraman et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: